May 3, 2018 by Brian FeroldiIQVIA Holdings Delivers on Its PromisesBusiness is booming for the healthcare services provider.
May 3, 2018 by Brian FeroldiWhy Abiomed Stock Is Flying High TodayThe company reported better-than-expected results and issued bullish guidance.
May 3, 2018 by Brian FeroldiHere's Why DexCom Is Surging TodayTraders cheer after the company reports better-than-expected results and boosts guidance. Here's what investors need to know.
May 3, 2018 by Brian FeroldiFormFactor Makes the Best of a Tough SituationIt's awfully hard to post growth when your largest customer pulls back on its spending.
May 2, 2018 by Brian FeroldiHCA Healthcare's Profits JumpHigher admissions and asset sales have revenue and net income marching in the right direction.
May 2, 2018 by Brian FeroldiPaycom Software Starts 2018 Strong, Increases GuidanceRapid revenue and profit growth continue for the HR software provider.
May 1, 2018 by Brian FeroldiTax Savings Drive NIC's Profits HigherWhile expenses continue to put pressure on profits, a lower tax rate allowed NIC's bottom line to move in the right direction.
May 1, 2018 by Brian FeroldiAppFolio Gains Customers; Profits SurgeThe business continues to scale beautifully as new customers flock to its software platforms.
May 1, 2018 by Brian FeroldiWhy Tenet Healthcare Is Soaring TodayTraders cheer after the company reports better-than-expected results and provides upbeat guidance.
Apr 27, 2018 by Brian FeroldiResMed's Profits Jump 32%Operating leverage and a lower tax rate allowed ResMed's net income to continue to soar. Here's what investors need to know.
Apr 27, 2018 by Brian FeroldiCullen/Frost Bankers Boosts Its Dividend 17.5%Business is booming at the regional bank.
Apr 27, 2018 by Brian FeroldiWhy Exact Sciences Is Soaring TodayTraders cheer after the company reports expectation-smashing results.
Apr 26, 2018 by Brian FeroldiThis Explains Why NovoCure Is Surging TodayShares jumped even though the company reported worse-than-expected results. What's going on?
Apr 26, 2018 by Brian FeroldiHere's Why Alexion Pharmaceuticals Is Surging TodayTraders cheer an upbeat earnings report and positive clinical news. Here's what investors need to know.
Apr 26, 2018 by Brian FeroldiAfter a Bumpy Ride, Alkermes Confirms That It's Back on TrackThe biopharma reports healthy top-line growth and shares good news about its pipeline. Here's what investors need to know.
Apr 26, 2018 by Brian FeroldiHere's Why LeMaitre Vascular Inc. Is Falling TodayShares plunge after the company's first-quarter results miss the mark.
Apr 26, 2018 by Brian Feroldi, Sean Williams, and Maxx ChatskoThese 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?Our team of investing experts thinks these growth stocks are just getting warmed up.
Apr 25, 2018 by Brian FeroldiThis Explains Why Acadia Pharmaceuticals Is Selling Off TodayShares tumble after a major news outlet reports that the FDA is re-examining the safety profile of Acadia's drug Nuplazid. Here's what investors need to know.
Apr 25, 2018 by Brian Feroldi, Demitri Kalogeropoulos, and Leo Sun3 Top Stocks That Aren't on Wall Street's RadarBig money managers are ignoring these three gems. Here's why you shouldn't make the same mistake.